Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities.

BMJ Oncol · 2023 · PMC11234986 · PMID 39886515

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an important trendno p-value reported

19–23 ‘Globalisation’ is an important trend in industry-sponsored trials, particularly in emerging regions of Eastern Europe, Latin America, Asia, the Middle East and Africa. 24 This is per se a welcome phenomenon, given the scarcity of high-grade evidence to guide the application of cancer treatment in LMICs.

also in 450 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.